AR034009A1 - Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos - Google Patents
Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismosInfo
- Publication number
- AR034009A1 AR034009A1 ARP010105490A ARP010105490A AR034009A1 AR 034009 A1 AR034009 A1 AR 034009A1 AR P010105490 A ARP010105490 A AR P010105490A AR P010105490 A ARP010105490 A AR P010105490A AR 034009 A1 AR034009 A1 AR 034009A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- procedure
- obtaining
- cor2
- phenyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 2
- -1 -OR2 Chemical group 0.000 abstract 1
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical class C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 abstract 1
- 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 abstract 1
- 101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 125000004193 piperazinyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 229940076279 serotonin Drugs 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Thin Film Transistor (AREA)
Abstract
Nuevos derivados de benzotiofeno de fórmula general (1) un procedimiento para su obtención, las correspondientes composiciones y su utilización para la fabricación de un medicamento destinado al tratamiento de trastornos neurológicos, donde: n es 1, 2 o 3; z es C=O o -CHOH; R1 es H, alquilo C1-6, halógeno, -OR2, nitro, ciano, -NR3R4, -COR2, -CO2R2, -O-COR2, SO2NR3R4, -SO2R2, -SR2, o -CONR3R4; R2 es H, alquilo C1-6 o fenilo; R3 y R4 son independientes entre sí y significan H, alquilo C1-6 o fenilo, o bien R3 conjuntamente con R4 forman un anillo de morfolina, tiomorfolina o piperazina; Ar es un sistema bicíclico opcionalmente sustituido formado por un anillo heterocícliclo benzocondensado, siendo dicho anillo heterocíclico de 5, 6 o 7 eslabones, saturados o insaturado y conteniendo 1, 2 o 3 heteroátomos seleccionados entre N, O y S; una sal o un solvato farmacéuticamente aceptable, o cualquier isómero geométrico, isómero óptico o polimorfo del mismo. Estos nuevos compuestos se comportan como inhibidores de la receptación de serotonina y muestran elevada afinidad hacia el receptor de 5-HT1A.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200002914A ES2188344B1 (es) | 2000-11-29 | 2000-11-29 | Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR034009A1 true AR034009A1 (es) | 2004-01-21 |
Family
ID=8495887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010105490A AR034009A1 (es) | 2000-11-29 | 2001-11-27 | Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US20040034219A1 (es) |
| EP (1) | EP1337528B1 (es) |
| JP (1) | JP2004514719A (es) |
| KR (1) | KR20030066689A (es) |
| CN (1) | CN1478088A (es) |
| AP (1) | AP2003002801A0 (es) |
| AR (1) | AR034009A1 (es) |
| AT (1) | ATE272634T1 (es) |
| AU (1) | AU2002215157A1 (es) |
| BG (1) | BG107851A (es) |
| BR (1) | BR0115708A (es) |
| CA (1) | CA2429892A1 (es) |
| CZ (1) | CZ20031398A3 (es) |
| DE (1) | DE60104717T2 (es) |
| EA (1) | EA200300519A1 (es) |
| EE (1) | EE200300245A (es) |
| ES (2) | ES2188344B1 (es) |
| GE (1) | GEP20043366B (es) |
| HR (1) | HRP20030407A2 (es) |
| HU (1) | HUP0303568A3 (es) |
| IL (1) | IL155966A0 (es) |
| IS (1) | IS6824A (es) |
| MA (1) | MA26963A1 (es) |
| MX (1) | MXPA03004875A (es) |
| NO (1) | NO20032332L (es) |
| NZ (1) | NZ525950A (es) |
| OA (1) | OA12536A (es) |
| PE (1) | PE20020692A1 (es) |
| PL (1) | PL362982A1 (es) |
| PT (1) | PT1337528E (es) |
| SI (1) | SI1337528T1 (es) |
| SK (1) | SK6202003A3 (es) |
| TR (1) | TR200402779T4 (es) |
| WO (1) | WO2002044170A2 (es) |
| ZA (1) | ZA200303858B (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2323451T7 (es) * | 2001-07-20 | 2011-08-01 | Psychogenics Inc. | Tratamiento para el trastorno de hiperactividad con deficit de atencion. |
| ES2307919T3 (es) | 2002-03-27 | 2008-12-01 | Glaxo Group Limited | Derivados de quinolina y su uso como ligandos de 5-ht6. |
| MXPA05007379A (es) | 2003-01-13 | 2006-02-10 | Dynogen Pharmaceuticals Inc | Metodo para tratar nauseas, vomito, esfuerzo por vomitar o cualquier combinacion de los mismos. |
| US7276603B2 (en) | 2003-05-02 | 2007-10-02 | Wyeth | Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use |
| DK1558582T3 (da) | 2003-07-22 | 2006-05-08 | Arena Pharm Inc | Diaryl og arylheteroarylureaderivater som modulatorer af aktiviteten af 5-HT2A-serotoninreceptoren anvendelige til profylakse eller behandling af forstyrrelser relateret dertil |
| DE102004023506A1 (de) * | 2004-05-10 | 2005-12-01 | Grünenthal GmbH | Kettenverlängerte substituierte Cyclohexyl-1,4-diamin-Derivate |
| DE102004023501A1 (de) * | 2004-05-10 | 2005-12-01 | Grünenthal GmbH | Oxosubstituierte Cyclohexyl-1,4-diamin-Derivate |
| DE102004023632A1 (de) * | 2004-05-10 | 2005-12-08 | Grünenthal GmbH | Substituierte Cyclohexylcarbonsäure-Derivate |
| DE102004023522A1 (de) * | 2004-05-10 | 2005-12-01 | Grünenthal GmbH | Substituierte Cyclohexyl-1,4-diamin-Derivate |
| DE102004023508A1 (de) * | 2004-05-10 | 2005-12-08 | Grünenthal GmbH | Säurederivate substituierter Cyclohexyl-1,4-diamine |
| DE102004023635A1 (de) * | 2004-05-10 | 2006-04-13 | Grünenthal GmbH | Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate |
| DE102004023507A1 (de) * | 2004-05-10 | 2005-12-01 | Grünenthal GmbH | Substituierte Cyclohexylessigsäure-Derivate |
| US7881267B2 (en) * | 2004-06-04 | 2011-02-01 | Hewlett-Packard Development Company, L.P. | Portable computing device for wireless communications and method of operation |
| DE102004063797A1 (de) * | 2004-12-30 | 2006-07-13 | Schwarz Pharma Ag | Sauerstoffhaltige annelierte Phenylpiperazin- und Phenyldiazepancarboxamide |
| TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| WO2009074607A1 (en) | 2007-12-12 | 2009-06-18 | Glaxo Group Limited | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline |
| WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| CN101619056B (zh) * | 2008-07-02 | 2013-07-17 | 石药集团中奇制药技术（石家庄）有限公司 | 苯并噻吩烷醇哌嗪衍生物及其作为抗抑郁症药物的应用 |
| US9126946B2 (en) | 2008-10-28 | 2015-09-08 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto |
| CN104337812B (zh) | 2013-07-29 | 2018-09-14 | 广东东阳光药业有限公司 | 取代的杂芳基化合物及其使用方法和用途 |
| WO2016192657A1 (en) | 2015-06-03 | 2016-12-08 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use and use thereof |
| MX2017016413A (es) | 2015-06-12 | 2018-08-01 | Axovant Sciences Gmbh | Derivados de diaril y arilheteroaril urea como moduladores del receptor 5ht2a de serotonina útiles para la profilaxis y el tratamineto de un trastorno conductual del sueño rem. |
| RU2018103338A (ru) | 2015-07-15 | 2019-08-15 | Аксовант Сайенсиз Гмбх | Производные диарил- и арилгетероарилмочевины для профилактики и лечения галлюцинаций, ассоциированных с нейродегенеративным заболеванием |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4487773A (en) * | 1981-03-16 | 1984-12-11 | Mead Johnson & Company | 1,2,4-Triazol-3-one antidepressants |
| ZA929008B (en) * | 1991-12-13 | 1993-05-21 | Bristol Myers Squibb Co | Piperazinyl- and piperidinyl-cyclohexanols. |
| FR2692264B1 (fr) * | 1992-06-12 | 1994-08-05 | Adir | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant. |
| US5693804A (en) * | 1994-11-17 | 1997-12-02 | Molecular Geriatrics Corporation | Substituted 1-aryl-3-piperazin-1'-yl propanones |
| US5658909A (en) * | 1994-11-17 | 1997-08-19 | Molecular Geriatrics Corporation | Certain substituted 1-aryl-3-piperazin-1'-yl propanones to treat Alzheimer's Disease |
| ES2128266B1 (es) * | 1997-07-08 | 2000-01-16 | Vita Invest Sa | Compuestos derivados de tiofeno y benzotiofeno y utilizacion y composicion correspondientes. |
-
2000
- 2000-11-29 ES ES200002914A patent/ES2188344B1/es not_active Expired - Fee Related
-
2001
- 2001-11-19 SI SI200130192T patent/SI1337528T1/xx unknown
- 2001-11-19 CA CA002429892A patent/CA2429892A1/en not_active Abandoned
- 2001-11-19 AT AT01983737T patent/ATE272634T1/de not_active IP Right Cessation
- 2001-11-19 MX MXPA03004875A patent/MXPA03004875A/es unknown
- 2001-11-19 EP EP01983737A patent/EP1337528B1/en not_active Expired - Lifetime
- 2001-11-19 US US10/432,697 patent/US20040034219A1/en not_active Abandoned
- 2001-11-19 DE DE60104717T patent/DE60104717T2/de not_active Expired - Fee Related
- 2001-11-19 GE GE5158A patent/GEP20043366B/en unknown
- 2001-11-19 OA OA1200300144A patent/OA12536A/en unknown
- 2001-11-19 EA EA200300519A patent/EA200300519A1/ru unknown
- 2001-11-19 CN CNA018196004A patent/CN1478088A/zh active Pending
- 2001-11-19 HU HU0303568A patent/HUP0303568A3/hu unknown
- 2001-11-19 PL PL01362982A patent/PL362982A1/xx unknown
- 2001-11-19 SK SK620-2003A patent/SK6202003A3/sk unknown
- 2001-11-19 WO PCT/IB2001/002211 patent/WO2002044170A2/en active IP Right Grant
- 2001-11-19 AP APAP/P/2003/002801A patent/AP2003002801A0/en unknown
- 2001-11-19 NZ NZ525950A patent/NZ525950A/en unknown
- 2001-11-19 TR TR2004/02779T patent/TR200402779T4/xx unknown
- 2001-11-19 CZ CZ20031398A patent/CZ20031398A3/cs unknown
- 2001-11-19 IL IL15596601A patent/IL155966A0/xx unknown
- 2001-11-19 KR KR10-2003-7007272A patent/KR20030066689A/ko not_active Application Discontinuation
- 2001-11-19 EE EEP200300245A patent/EE200300245A/xx unknown
- 2001-11-19 ES ES01983737T patent/ES2225623T3/es not_active Expired - Lifetime
- 2001-11-19 PT PT01983737T patent/PT1337528E/pt unknown
- 2001-11-19 BR BR0115708-6A patent/BR0115708A/pt not_active IP Right Cessation
- 2001-11-19 JP JP2002546540A patent/JP2004514719A/ja active Pending
- 2001-11-19 AU AU2002215157A patent/AU2002215157A1/en not_active Abandoned
- 2001-11-26 PE PE2001001181A patent/PE20020692A1/es not_active Application Discontinuation
- 2001-11-27 AR ARP010105490A patent/AR034009A1/es not_active Application Discontinuation
-
2003
- 2003-05-19 ZA ZA200303858A patent/ZA200303858B/en unknown
- 2003-05-19 MA MA27164A patent/MA26963A1/fr unknown
- 2003-05-20 HR HR20030407A patent/HRP20030407A2/hr not_active Application Discontinuation
- 2003-05-22 NO NO20032332A patent/NO20032332L/no not_active Application Discontinuation
- 2003-05-22 IS IS6824A patent/IS6824A/is unknown
- 2003-05-27 BG BG107851A patent/BG107851A/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR034009A1 (es) | Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos | |
| PA8522001A1 (es) | Pro - farmacos de derivados de 4- fenil - piridin. | |
| AR048289A1 (es) | Eteres de anillos imidazo sulfona sustituidos. | |
| AR054560A1 (es) | Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
| PE20041040A1 (es) | Compuestos derivados de amidas como inhibidores de 11-beta-hidroxiesteroide-deshidroxigenasa de tipo 1 | |
| AR043111A1 (es) | Derivados monoacilados de o-fenilendiaminas | |
| ES2315853T3 (es) | Tetrahidroquinolinonas y su uso como antagonistas de receptores de glutamato metabotropico. | |
| AR053415A1 (es) | Inhibidores dipeptidil peptidasa iv, composiciones farmaceuticas que los contienen y procesos para la preparacion de los compuestos y de la composicion | |
| PE20011371A1 (es) | Derivados de 3-(3-isopropil-5-metil-4h-1,2,4-triazol-4-il)-exo-8-azabiciclo[3.2.1]octano como antagonistas de los receptores de quimiocina ccr5 | |
| PE20030447A1 (es) | Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol-3-il)-sustituidos y su obtencion | |
| AR047098A1 (es) | Derivados de arilanilina como agonistas del receptor adrenergico beta2 | |
| PE20020470A1 (es) | Derivados de pirazol como inhibidores de las enzimas proteina quinasas | |
| AR046297A1 (es) | Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo | |
| ATE431345T1 (de) | Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate | |
| AR004320A1 (es) | Nuevos compuestos de pirimidina condensados biciclicos; un procedimiento para su preparacion; composiciones farmaceuticas que los contienen y su usocomo agentes terapeuticos, en particular como inhibidores de la tirosina quinasa. | |
| AR056762A1 (es) | (4 -(6-halo-7- substituidos -2,4- dioxo-1,4- dihidro-2h-quinazolin-3-il- fenil)-5- cloro- tiophen-2- il sulfonilureas y formas y metodos | |
| PE20061156A1 (es) | Derivados de benzamida como agentes inhibidores del transportador de glicina | |
| AR009413A1 (es) | Un compuesto, el cual es un derivado de distamicina benzoheterociclico, su utilizacion, un procedimiento para producirlo y una composicionfarmaceutica que lo comprende | |
| PE20020735A1 (es) | Derivados de quinazolona como antagonistas de receptores adrenergicos alfa-1a/b | |
| PE20191784A1 (es) | Compuestos inhibidores de vmat2, composiciones y metodos relativos a los mismos | |
| AR015712A1 (es) | Derivados de 3,4-dihidro-tieno[2,3-d]pirimidina-3-sustituidos y su uso para la preparacion de composiciones farmaceuticas | |
| RU2008144952A (ru) | Производные аминометилпиридина, их получение и их применение в терапии | |
| EA202191968A1 (ru) | Новые замещенные производные сульфонилмочевины | |
| CL2021002621A1 (es) | Compuestos de hexahidro-1h-pirazino[1,2-a]pirazina para el tratamiento de una enfermedad autoinmunitaria | |
| NO20050612L (no) | Pyrrolidinderivater som oksytocinantagonister |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |